-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Aveanna Healthcare (NASDAQ:AVAH) Price Target Cut to $2.50 by Analysts at Stephens
Aveanna Healthcare (NASDAQ:AVAH) Price Target Cut to $2.50 by Analysts at Stephens
Aveanna Healthcare (NASDAQ:AVAH – Get Rating) had its target price decreased by Stephens to $2.50 in a research report report published on Tuesday, Stock Target Advisor reports.
AVAH has been the subject of several other reports. Jefferies Financial Group lowered shares of Aveanna Healthcare from a buy rating to a hold rating and set a $2.50 price objective for the company. in a research note on Friday, July 22nd. Bank of America lowered shares of Aveanna Healthcare from a neutral rating to an underperform rating and dropped their price objective for the stock from $3.00 to $2.00 in a research note on Tuesday, June 21st. Credit Suisse Group dropped their price objective on shares of Aveanna Healthcare to $5.50 in a research note on Friday, July 22nd. Barclays dropped their price objective on shares of Aveanna Healthcare from $7.00 to $5.00 and set an overweight rating for the company in a research note on Friday, August 19th. Finally, Truist Financial lowered shares of Aveanna Healthcare from a buy rating to a hold rating and set a $2.50 price objective for the company. in a research note on Tuesday, July 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Aveanna Healthcare has a consensus rating of Moderate Buy and a consensus price target of $5.30.
Get Aveanna Healthcare alerts:Aveanna Healthcare Trading Up 1.2 %
AVAH stock opened at $1.69 on Tuesday. The firm has a fifty day moving average price of $2.23 and a 200 day moving average price of $3.19. Aveanna Healthcare has a fifty-two week low of $1.66 and a fifty-two week high of $9.73. The company has a debt-to-equity ratio of 6.19, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a market cap of $314.20 million, a PE ratio of -0.56 and a beta of 1.03.
Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last posted its earnings results on Wednesday, August 10th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.03). Aveanna Healthcare had a negative net margin of 33.32% and a positive return on equity of 9.57%. During the same quarter in the previous year, the business earned $0.08 earnings per share. Sell-side analysts anticipate that Aveanna Healthcare will post 0.16 earnings per share for the current fiscal year.Institutional Trading of Aveanna Healthcare
Institutional investors and hedge funds have recently made changes to their positions in the company. Regentatlantic Capital LLC purchased a new stake in shares of Aveanna Healthcare during the first quarter worth about $34,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $25,000. AE Wealth Management LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $31,000. Virginia Retirement Systems ET AL purchased a new stake in shares of Aveanna Healthcare during the first quarter worth about $50,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $38,000. 92.00% of the stock is currently owned by institutional investors.
About Aveanna Healthcare
(Get Rating)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
See Also
- Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
- 3 Low Beta Defensive Stocks for a Tough Market
- It Could Be a September to Remember for These 3 Stocks
- Peak Inflation Sets the Bottom for Brinker International Stock
- Can Roblox Reverse its Falling Bookings Amid Rising Engagements
- Broadcom Bounces From Institutional Bottom
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
Aveanna Healthcare (NASDAQ:AVAH – Get Rating) had its target price decreased by Stephens to $2.50 in a research report report published on Tuesday, Stock Target Advisor reports.
據Stock Target Advisor報道,在週二發佈的一份研究報告中,Aveanna Healthcare(納斯達克:AVAH-GET評級)的目標價被斯蒂芬斯下調至2.5美元。
AVAH has been the subject of several other reports. Jefferies Financial Group lowered shares of Aveanna Healthcare from a buy rating to a hold rating and set a $2.50 price objective for the company. in a research note on Friday, July 22nd. Bank of America lowered shares of Aveanna Healthcare from a neutral rating to an underperform rating and dropped their price objective for the stock from $3.00 to $2.00 in a research note on Tuesday, June 21st. Credit Suisse Group dropped their price objective on shares of Aveanna Healthcare to $5.50 in a research note on Friday, July 22nd. Barclays dropped their price objective on shares of Aveanna Healthcare from $7.00 to $5.00 and set an overweight rating for the company in a research note on Friday, August 19th. Finally, Truist Financial lowered shares of Aveanna Healthcare from a buy rating to a hold rating and set a $2.50 price objective for the company. in a research note on Tuesday, July 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Aveanna Healthcare has a consensus rating of Moderate Buy and a consensus price target of $5.30.
Avah一直是其他幾篇報道的主題。傑富瑞金融集團將Aveanna Healthcare的股票評級從買入下調至持有評級,併為該公司設定了2.50美元的目標價。在7月22日星期五的一份研究報告中。6月21日,週二,美國銀行在一份研究報告中將Aveanna Healthcare的股票評級從中性下調至表現不佳,並將該股的目標價從3.00美元下調至2.00美元。瑞士信貸集團在7月22日星期五的一份研究報告中將Aveanna Healthcare的股票目標價下調至5.50美元。巴克萊將Aveanna Healthcare的股票目標價從7.00美元下調至5.00美元,並在8月19日星期五的一份研究報告中為該公司設定了增持評級。最後,Truist Financial將Aveanna Healthcare的股票評級從買入下調至持有評級,併為該公司設定了2.50美元的目標價。在7月5日星期二的一份研究報告中。一名投資分析師將該股評級為賣出,三名分析師給出了持有評級,五名分析師給出了買入評級,一名分析師給出了該公司股票的強力買入評級。根據MarketBeat的數據,Aveanna Healthcare的共識評級為中等買入,共識目標價為5.30美元。
Aveanna Healthcare Trading Up 1.2 %
Aveanna Healthcare交易上漲1.2%
AVAH stock opened at $1.69 on Tuesday. The firm has a fifty day moving average price of $2.23 and a 200 day moving average price of $3.19. Aveanna Healthcare has a fifty-two week low of $1.66 and a fifty-two week high of $9.73. The company has a debt-to-equity ratio of 6.19, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a market cap of $314.20 million, a PE ratio of -0.56 and a beta of 1.03.
週二,Avah的股價開盤報1.69美元。該公司的50日移動平均價為2.23美元,200日移動平均價為3.19美元。Aveanna Healthcare的股價為1.66美元,為52周低點,52周高點為9.73美元。該公司的負債權益比率為6.19,速動比率為0.81,流動比率為0.81。該公司市值為3.142億美元,市盈率為-0.56,貝塔係數為1.03。
Institutional Trading of Aveanna Healthcare
Aveanna Healthcare的機構交易
Institutional investors and hedge funds have recently made changes to their positions in the company. Regentatlantic Capital LLC purchased a new stake in shares of Aveanna Healthcare during the first quarter worth about $34,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $25,000. AE Wealth Management LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $31,000. Virginia Retirement Systems ET AL purchased a new stake in shares of Aveanna Healthcare during the first quarter worth about $50,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $38,000. 92.00% of the stock is currently owned by institutional investors.
機構投資者和對衝基金最近對他們在該公司的頭寸進行了調整。RegentAtlantic Capital LLC在第一季度購買了Aveanna Healthcare的新股份,價值約3.4萬美元。Zurcher Kantonalbank蘇黎世廣東銀行在第二季度購買了價值約25,000美元的Aveanna Healthcare新股。AE Wealth Management LLC在第二季度購買了價值約31,000美元的Aveanna Healthcare新股。弗吉尼亞退休系統等公司在第一季度購買了價值約5萬美元的Aveanna Healthcare新股。最後,SG America Securities LLC在第二季度購買了價值約3.8萬美元的Aveanna Healthcare新股。92.00%的股票目前由機構投資者持有。
About Aveanna Healthcare
關於Aveanna Healthcare
(Get Rating)
(獲取評級)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
Aveanna Healthcare Holdings Inc是一家多元化的家庭護理平臺公司,在美國提供私人值班護理(PDN)、成人家庭健康和臨終關懷、家庭兒科治療和腸內營養服務。其以患者為中心的護理交付平臺允許患者留在家裏,並最大限度地減少對醫院等高成本護理機構的過度利用。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
- 3 Low Beta Defensive Stocks for a Tough Market
- It Could Be a September to Remember for These 3 Stocks
- Peak Inflation Sets the Bottom for Brinker International Stock
- Can Roblox Reverse its Falling Bookings Amid Rising Engagements
- Broadcom Bounces From Institutional Bottom
- 免費獲取StockNews.com關於Aveanna Healthcare(Avah)的研究報告
- 3低貝塔防禦性股票為艱難的市場做準備
- 對於這三隻股票來説,這可能是一個值得記住的9月
- 通脹峯值為布林克國際股票設定底部
- 在預訂增加的情況下,Roblox能否扭轉預訂量下降的局面
- 博通從機構底部反彈
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
接受Aveanna Healthcare Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Aveanna Healthcare和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧